TREA

97409699 - AMPHISTA

Follow

Information

  • Trademark
  • 97409699
  • Serial Number
    97409699
  • Registration Number
    7172943
  • Filing Date
    May 13, 2022
    3 years ago
  • Registration Date
    September 26, 2023
    2 years ago
  • Transaction Date
    April 27, 2025
    9 months ago
  • Status Date
    September 26, 2023
    2 years ago
  • Published for Opposition Date
    July 11, 2023
    2 years ago
  • Location Date
    September 26, 2023
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BRACEY, KAREN
  • Attorney Docket Number
    235211200005
    Attorney Name
    Rob LeBlanc
    Law Office Assigned Location Code
    M70
  • Owners
Information
Mark Drawing Code
4
Mark Identification
AMPHISTA
Case File Statements
  • GS0051: Pharmaceuticals, medicinal and veterinary preparations for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; diagnostic preparations for medical and veterinary use; medicines and biotechnological preparations for medical use for the diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; biological and chemical reagents for medical use; pharmaceutical drugs for medical purposes for use in diagnosis and treatment of damaged tissue, dermatological diseases and disorders, infectious diseases, pain, obesity, cognitive disorders, inflammation, viral diseases and disorders, neurological diseases and disorders, endocrine diseases and disorders, metabolic diseases and disorders, genitourinary diseases and disorders, musculoskeletal diseases and disorders, cardiovascular diseases and disorders, cardiopulmonary diseases and disorders, oncological diseases and disorders, respiratory diseases and disorders, hepatological diseases and disorders, gastrointestinal diseases and disorders, psychiatric diseases and disorders and immune system diseases and disorders; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; with none of the above for use in the field of agriculture, horticulture, forestry, agronomy or the home and garden sector
  • GS0011: Chemicals for use in science; chemical compositions and agents for use in science; chemical preparations for use in the manufacture of pharmaceutical drugs; biological preparations for use in science; chemicals for biotechnological manufacturing processes; diagnostic preparations used for scientific or research use; reagents used for scientific or research use; proteins in raw material form for scientific or research use; with none of the above for use in the field of agriculture, horticulture, forestry, agronomy or the home and garden sector
  • GS0421: Scientific and technological services, namely, scientific analysis, testing, engineering, development, research and design in the field of drug discovery and the identification and development of pharmaceutical and medicinal preparations; consultancy relating to product research and development in the field of pharmaceutical and medical preparations for therapeutic use; research and development in the field of medical diagnostics; biotechnological and chemical testing; research and development in the pharmaceutical, chemical and biotechnological fields; research and development in the field of medicinal preparations; drug discovery services; development of pharmaceutical preparations and medicines; pharmaceutical drug development services; with none of the above for use in the field of agriculture, horticulture, forestry, agronomy or the home and garden sector
Case File Event Statements
  • 5/17/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 5/18/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 6/2/2022 - 3 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 6/2/2022 - 3 years ago
    4 - TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED Type: TAEA
  • 2/14/2023 - 2 years ago
    5 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 2/14/2023 - 2 years ago
    6 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 2/14/2023 - 2 years ago
    7 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 2/14/2023 - 2 years ago
    8 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 2/14/2023 - 2 years ago
    9 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/14/2023 - 2 years ago
    10 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 2/15/2023 - 2 years ago
    11 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 2/15/2023 - 2 years ago
    12 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 2/15/2023 - 2 years ago
    13 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 3/2/2023 - 2 years ago
    14 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/3/2023 - 2 years ago
    15 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/3/2023 - 2 years ago
    16 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/3/2023 - 2 years ago
    17 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/22/2023 - 2 years ago
    18 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/22/2023 - 2 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 5/24/2023 - 2 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/31/2023 - 2 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/2/2023 - 2 years ago
    22 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 6/7/2023 - 2 years ago
    23 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 6/21/2023 - 2 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/11/2023 - 2 years ago
    25 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/11/2023 - 2 years ago
    26 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/26/2023 - 2 years ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 9/26/2023 - 2 years ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/22/2025 - 9 months ago
    29 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 4/22/2025 - 9 months ago
    33 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 4/22/2025 - 9 months ago
    32 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 4/22/2025 - 9 months ago
    31 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 4/22/2025 - 9 months ago
    30 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN